FDA Recalls Tri-Coast Pharmacy Testosterone Propionate Due to Sterility Concerns
Tri-Coast Pharmacy is recalling 347 vials of compounded Testosterone Propionate 100 mg/mL because the agency cannot ensure the products are sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. According to the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving sterile products where sterility assurance is compromised, posing a risk of infection.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for Testosterone Propionate 100 mg/mL (5 mL) compounded by Tri-Coast Pharmacy. The recall involves 347 vials distributed nationwide. The specific reason for the recall is a lack of assurance of sterility.
The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. Known lot codes and expiration dates include 07272016A (01/23/2017), 07052016A (12/31/2016), and 11072016A (05/06/2017).
Consumers who have this product should contact their healthcare provider or pharmacist for instructions on how to dispose of the medication or obtain a replacement. The FDA classifies this as a Class II recall, meaning there is a reasonable probability that the use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Testosterone Propionate 100 mg/mL, (5 ML). Compounded by Tri-Coast Pharmacy
- Manufacturer
- Tri-Coast Pharmacy
- Hazard
- Affected units
- 347
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 07052016A (12/31/2016)
- 11072016A (05/06/2017).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTestosterone Propionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- HighTestosterone Propionate Injectable Vials Recalled Over Sterility Assurance
FDA (Drugs) · 2022-07-20
- SeverePartell Specialty Pharmacy Recalls Testosterone Propionate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SevereTestosterone Cypionate Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereWells Pharmacy Recalls Testosterone Propionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- HighUniversity Compounding Pharmacy Recalls Testosterone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-09-18